COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH
Aim. To study the efficacy and safety of the use of combined antihypertensive therapy with perindopril (as monotherapy or as a fixed combination with amlodipine or indapamide) together with lipid-lowering therapy with rosuvastatin, and to assess the level of satisfaction of doctors with the efficacy...
Saved in:
| Main Author: | O. M. Drapkina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2017-05-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1439 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS
by: O. D. Ostroumova, et al.
Published: (2017-02-01) -
TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2
by: O. M. Drapkina, et al.
Published: (2017-07-01) -
Optimal treatment strategies in comorbid patients with hypertension and dyslipidemia: the role of fixed-dose combinations
by: A. A. Sokolova, et al.
Published: (2023-12-01) -
Effectiveness of triple fixed-dose combination in patients with inadequate blood pressure control
by: E. V. Zbyshevskaya, et al.
Published: (2022-02-01) -
New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients
by: Yu. A. Karpov, et al.
Published: (2023-11-01)